litlas
Log inCreate account

Nancy L. Geller

Active 1978–2025

Also published as
NANCY L. GELLER · Nancy L Geller
98
Papers
19,555
Citations
76
h-index
96
i10-index

Citations

Citations per year for Nancy L. Geller1983: 4 citations1984: 4 citations1985: 9 citations1986: 5 citations1987: 24 citations1988: 21 citations1989: 32 citations1990: 46 citations1991: 49 citations1992: 36 citations1993: 38 citations1994: 48 citations1995: 48 citations1996: 48 citations1997: 75 citations1998: 70 citations1999: 67 citations2000: 63 citations2001: 80 citations2002: 62 citations2003: 70 citations2004: 85 citations2005: 76 citations2006: 70 citations2007: 82 citations2008: 50 citations2009: 78 citations2010: 62 citations2011: 72 citations2012: 80 citations2013: 67 citations2014: 80 citations2015: 71 citations2016: 75 citations2017: 87 citations2018: 101 citations2019: 276 citations2020: 358 citations2021: 417 citations2022: 340 citations2023: 233 citations2024: 487 citations2025: 198 citations2026: 11 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,087 citing papers, 28.5% of this breakdownUnited Kingdom: 651 citing papers, 8.9% of this breakdownGermany: 425 citing papers, 5.8% of this breakdownItaly: 404 citing papers, 5.5% of this breakdownCanada: 367 citing papers, 5% of this breakdownNetherlands: 339 citing papers, 4.6% of this breakdownFrance: 312 citing papers, 4.3% of this breakdownSpain: 226 citing papers, 3.1% of this breakdownChina: 194 citing papers, 2.7% of this breakdownAustralia: 189 citing papers, 2.6% of this breakdownJapan: 184 citing papers, 2.5% of this breakdownSwitzerland: 162 citing papers, 2.2% of this breakdown
0%28.5%Other 24.3%

Institutions

Fields

  • Medicine82.8%
  • Biochemistry, Genetics and Molecular Biology4.1%
  • Pharmacology, Toxicology and Pharmaceutics3.5%
  • Mathematics1.4%
  • Immunology and Microbiology1%
  • Decision Sciences1%
  • Other6.2%

Topics

  • Hematopoietic Stem Cell Transplantation3.5%
  • Cardiac Valve Diseases and Treatments2.7%
  • Cardiac Imaging and Diagnostics2.4%
  • Cardiovascular Function and Risk Factors2.4%
  • Acute Myeloid Leukemia Research2.4%
  • Bladder and Urothelial Cancer Treatments2.1%
  • Other84.5%

Coauthors

All papers

Open in search
  1. Treatment for Mild Chronic Hypertension during Pregnancy

    Authors: Alan Tita, Jeff M. Szychowski, Kim Boggess, Lorraine Dugoff, Baha M. Sibai, Kirsten Lawrence, Brenna L. Hughes, Joseph Bell, Kjersti M. Aagaard, Rodney K. Edwards, Kelly S. Gibson, David M. Haas, Lauren A. Plante, Torri D. Metz, Brian M. Casey, Sean Esplin, Sherri Longo, Matthew R. Hoffman, George R. Saade, Kara K. Hoppe, Janelle Foroutan, Methodius G. Tuuli, Michelle Owens, Hyagriv N. Simhan, Heather A. Frey, Todd Rosen, Anna Palatnik, Susan Baker, Phyllis August, Uma M. Reddy, Wendy Kinzler, Emily Su, Iris Krishna, Nicki Nguyen, Mary E. Norton, Daniel Skupski, Yasser Y. El‐Sayed, Dotum Ogunyemi, Zorina S. Galis, Lorie M. Harper, Namasivayam Ambalavanan, Nancy L. Geller, Suzanne Oparil, Gary Cutter, William W. Andrews - New England Journal of Medicine 2022 cited by 529

  2. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

    Authors: Andrew R. Harper, Anuj Goel, Christopher Grace, Kate Thomson, Steffen E. Petersen, Xiao Hua Xu, Adam Waring, Elizabeth Ormondroyd, Christopher M. Kramer, Carolyn Y. Ho, Stefan Neubauer, HCMR Investigators, Paul Kolm, Raymond Y. Kwong, Sarahfaye Dolman, Patrice Desvigne‐Nickens, John Dimarco, Nancy L. Geller, Dong‐Yun Kim, Cheng Zhang, William S. Weintraub, Theodore P. Abraham, Lisa Anderson, Evan Appelbaum, Camillo Autore, Colin Berry, Elena Biagini, William Bradlow, Chiara Bucciarelli‐Ducci, Amedeo Chiribiri, Lubna Choudhury, Andrew Crean, Dana Dawson, Milind Y. Desai, Eleanor Elstein, Andrew Flett, Matthias G. Friedrich, Stephen B. Heitner, Adam Helms, Daniel Jacoby, Han Kim, Bette Kim, Éric Larose, Masliza Mahmod, Heiko Mahrholdt, Martin S. Maron, Gerry P McCann, Michelle Michels, Saidi Mohiddin, Sherif F. Nagueh, David E. Newby, Iacopo Olivotto, Anjali Owens, François Pierre-Mongeon, Sanjay Prasad, Ornella Rimoldi, Michael Salerno, Jeanette Schulz‐Menger, Mark V. Sherrid, Peter Swoboda, Albert C. van Rossum, Jonathan W. Weinsaft, James A. White, Eric E. Williamson, Rafik Tadros, James S. Ware, Connie R. Bezzina, Martin Farrall, Hugh Watkins - Nature Genetics 2021 cited by 339

  3. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry

    Authors: Stefan Neubauer, Paul Kolm, Carolyn Y. Ho, Raymond Y. Kwong, Milind Y. Desai, Sarahfaye Dolman, Evan Appelbaum, Patrice Desvigne‐Nickens, John Dimarco, Matthias G. Friedrich, Nancy L. Geller, Andrew R. Harper, Petr Jarolı́m, Michael Jerosch‐Herold, Dong‐Yun Kim, Martin S. Maron, Jeanette Schulz‐Menger, Stefan K. Piechnik, Kate Thomson, Cheng Zhang, Hugh Watkins, William S. Weintraub, Christopher M. Kramer, Masliza Mahmod, Daniel Jacoby, James A. White, Amedeo Chiribiri, Adam Helms, Lubna Choudhury, Michelle Michels, William Bradlow, Michael Salerno, Stephen B. Heitner, Sanjay Prasad, Saidi Mohiddin, Peter Swoboda, Heiko Mahrholdt, Chiara Bucciarelli‐Ducci, Jonathan W. Weinsaft, Han Kim, Gerry P McCann, Albert C. van Rossum, Eric E. Williamson, Andrew Flett, Dana Dawson, François‐Pierre Mongeon, Iacopo Olivotto, Andrew Crean, Anjali Owens, Lisa Anderson, Elena Biagini, David E. Newby, Colin Berry, Bette Kim, Éric Larose, Theodore P. Abraham, Mark V. Sherrid, Sherif F. Nagueh, Ornella Rimoldi, Eleanor Elstein, Camillo Autore - Journal of the American College of Cardiology 2019 cited by 321

  4. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

    Authors: Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones, Anurag K. Singh, Mark R. Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Üstün, Masumi Ueda, Geoffrey L. Uy, Edmund K. Waller, Sumithra Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Hee‐Je Kim, Jan‐Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Nancy L. Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi‐Bin Chen, on behalf of the BMT-CTN 1506/MORPHO Study Investigators, Ed Agura, Jessica K. Altman, Achiles Anagnostopoulos, Sarah Anand, Andrew Artz, Walter E. Aulitzky, Sophia Balderman, Karen K. Ballen, Michael W. Becker, Yves Béguin, Leanne Berkahn, Zwi Berneman, Vijaya Raj Bhatt, Ian Bilmon, Francesca Bonifazi, Adrienne Briggs, Benedetto Bruno, Claudio G. Brunstein, Michael Byrne, Jenny Byrne, Mónica Cabrero, Roberto Cairoli, George Carrum, Jan Černý, Yi‐Bin Chen, June‐Won Cheong, Fabio Ciceri, Mercedes Colorado, Rachel J. Cook, Daniel R. Couriel, Charles Craddock, Lloyd E. Damon, Abhinav Deol, Yohan Desbrosses, Steve Devine, Carmela Di Grazia, Antonio Di Stasi, Ajoy Dias, Kathy Dorritie, James Essell, Tetsuya Eto, Sherif S. Farag, Édouard Forcade, Olga Frankfurt, Shin‐ichiro Fujiwara, Takahiro Fukuda, Kentaro Fukushima, Sabine Fürst, Tatsunori Goto, Aric C. Hall, Shunsuke Hatta, Yosr Hicheri, Mitchell E. Horwitz, Hsin‐An Hou, Jonathan How, Dianna S. Howard, Wei‐Hsun Hsu, Anne Huynh, David Irvine, Takayuki Ishikawa and 109 more - Journal of Clinical Oncology 2024 cited by 185

  5. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Authors: Bart L. Scott, Marcelo C. Pasquini, Brent R. Logan, Juan Wu, Steven M. Devine, David Porter, Richard T. Maziarz, Erica D. Warlick, Hugo F. Fernández, Edwin P. Alyea, Mehdi Hamadani, Asad Bashey, Sergio Giralt, Nancy L. Geller, Eric Leifer, Jennifer Le‐Rademacher, Adam Mendizabal, Mary M. Horowitz, H. Joachim Deeg, Mitchell E. Horwitz - Journal of Clinical Oncology 2017 cited by 666

  6. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention

    Authors: Naveen L. Pereira, Michael E. Farkouh, Derek So, Ryan J. Lennon, Nancy L. Geller, Verghese Mathew, Malcolm R. Bell, Jang‐Ho Bae, Myung Ho Jeong, Ivan Chavez, Paul Gordon, J. Dawn Abbott, Charles Cagin, Linnea M. Baudhuin, Yi-Ping Fu, Shaun G. Goodman, Ahmed Hasan, Erin Iturriaga, Amir Lerman, Mandeep S. Sidhu, Jean-François Tanguay, Liewei Wang, Richard Weinshilboum, Robert C. Welsh, Yves Rosenberg, Kent R. Bailey, Charanjit S. Rihal - JAMA 2020 cited by 404

  7. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

    Authors: Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser, Mingwei Fei, Sunil Abhyankar, Zaid Al‐Kadhimi, Amin M. Alousi, Joseph H. Antin, Sally Arai, Kate Bickett, Yi‐Bin Chen, Lloyd E. Damon, Yvonne A. Efebera, Nancy L. Geller, Sergio Giralt, Parameswaran Hari, Shernan G. Holtan, Mary M. Horowitz, David A. Jacobsohn, Richard J. Jones, Jane L. Liesveld, Brent R. Logan, Margaret L. MacMillan, Marco Mielcarek, Pierre Noël, Joseph Pidala, David Porter, Iskra Pusic, Ronald Sobecks, Scott R. Solomon, Daniel J. Weisdorf, Juan Wu, Marcelo C. Pasquini, John Koreth - The Lancet Haematology 2019 cited by 281

  8. Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy

    Authors: Naveen L. Pereira, Charanjit S. Rihal, Ryan J. Lennon, Gil Marcus, Sanskriti Shrivastava, Malcolm R. Bell, Derek So, Nancy L. Geller, Shaun G. Goodman, Ahmed Hasan, Amir Lerman, Yves Rosenberg, Kent R. Bailey, M. Hassan Murad, Michael E. Farkouh - JACC: Cardiovascular Interventions 2021 cited by 163

  9. Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery

    Authors: A. Marc Gillinov, Annetine C. Gelijns, Michael K. Parides, Joseph J. DeRose, Alan J. Moskowitz, Pierre Voisine, Gorav Ailawadi, Denis Bouchard, Peter K. Smith, Michael J. Mack, Michael A. Acker, John C. Mullen, Eric A. Rose, Helena Chang, John D. Puskas, Jean‐Philippe Couderc, Timothy J. Gardner, Robin Varghese, Keith A. Horvath, Steven F. Bolling, Robert E. Michler, Nancy L. Geller, Deborah D. Ascheim, Marissa A. Miller, Emilia Bagiella, Ellen Moquete, Paula Williams, Wendy C. Taddei‐Peters, Patrick T. O’Gara, Eugene H. Blackstone, Michael Argenziano - New England Journal of Medicine 2015 cited by 491

  10. Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial

    Authors: Bart L. Scott, Marcelo C. Pasquini, Mingwei Fei, Raphael Fraser, Juan Wu, Steve Devine, David L. Porter, Richard T. Maziarz, Erica D. Warlick, Hugo F. Fernández, Robert J. Soiffer, Edwin P. Alyea, Mehdi Hamadani, Asad Bashey, Sergio Giralt, Nancy L. Geller, Eric Leifer, Christopher S. Hourigan, Gege Gui, Adam Mendizabal, Mary M. Horowitz, H. Joachim Deeg, Mitchell E. Horwitz - Transplantation and Cellular Therapy 2021 cited by 141

  11. Sedentary Behavior and Cardiovascular Disease in Older Women

    Authors: John Bellettiere, Michael J. LaMonte, Kelly R. Evenson, Eileen Rillamas‐Sun, Jacqueline Kerr, I‐Min Lee, Chongzhi Di, Dori E. Rosenberg, Marcia L. Stefanick, David M. Büchner, Melbourne F. Hovell, Andrea Z. LaCroix, Jacques E. Rossouw, Shari Ludlam, Dale R. Burwen, Joan McGowan, Leslie Ford, Nancy L. Geller, Garnet L. Anderson, Ross Prentice, Charles Kooperberg, JoAnn E. Manson, Barbara V. Howard, Rebecca D. Jackson, Cynthia A. Thomson, Jean Wactawski‐Wende, Marian C. Limacher, R Wallace, Lewis Kuller, Sally A. Shumaker, Sally A. Shumaker - Circulation 2019 cited by 262

  12. Clopidogrel Pharmacogenetics

    Authors: Naveen L. Pereira, Charanjit S. Rihal, Derek So, Yves Rosenberg, Ryan J. Lennon, Verghese Mathew, Shaun G. Goodman, Richard M. Weinshilboum, Liewei Wang, Linnea M. Baudhuin, Amir Lerman, Ahmed Hasan, Erin Iturriaga, Yi-Ping Fu, Nancy L. Geller, Kent R. Bailey, Michael E. Farkouh - Circulation Cardiovascular Interventions 2019 cited by 221

  13. Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation

    Authors: Daniel J. Goldstein, Alan J. Moskowitz, Annetine C. Gelijns, Gorav Ailawadi, Michael K. Parides, Louis P. Perrault, Judy Hung, Pierre Voisine, François Dagenais, A. Marc Gillinov, Vinod H. Thourani, Michael Argenziano, James S. Gammie, Michael J. Mack, Philippe Demers, Pavan Atluri, Eric A. Rose, Karen O’Sullivan, Deborah Williams, Emilia Bagiella, Robert E. Michler, Richard D. Weisel, Marissa A. Miller, Nancy L. Geller, Wendy C. Taddei‐Peters, Peter K. Smith, Ellen Moquete, Jessica Overbey, Irving L. Kron, Patrick T. O’Gara, Michael A. Acker - New England Journal of Medicine 2015 cited by 977

  14. Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation

    Authors: Michael A. Acker, Michael K. Parides, Louis P. Perrault, Alan J. Moskowitz, Annetine C. Gelijns, Pierre Voisine, Peter K. Smith, Judy Hung, Eugene H. Blackstone, John D. Puskas, Michael Argenziano, James S. Gammie, Michael J. Mack, Deborah D. Ascheim, Emilia Bagiella, Ellen Moquete, T. Bruce Ferguson, Keith A. Horvath, Nancy L. Geller, Marissa A. Miller, Y. Joseph Woo, David A. D’Alessandro, Gorav Ailawadi, François Dagenais, Timothy J. Gardner, Patrick T. O’Gara, Robert E. Michler, Irving L. Kron - New England Journal of Medicine 2013 cited by 946

  15. A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

    Authors: Stephen E. Kimmel, Benjamin French, Scott E. Kasner, Julie A. Johnson, Jeffrey L. Anderson, Brian F. Gage, Yves Rosenberg, Charles S. Eby, Rosemary Madigan, Robert B. McBane, Sherif Z. Abdel‐Rahman, Scott M. Stevens, Steven H. Yale, Emile R. Mohler, Margaret C. Fang, Vinay Shah, Richard B. Horenstein, Nita A. Limdi, James A.S. Muldowney, Jaspal Gujral, Patrice Delafontaine, Robert J. Desnick, Thomas L. Ortel, Henny H. Billett, Robert C. Pendleton, Nancy L. Geller, Jonathan L. Halperin, Samuel Z. Goldhaber, Michael D. Caldwell, Robert M. Califf, Jonas H. Ellenberg - New England Journal of Medicine 2013 cited by 749

  16. Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial

    Authors: Edward A. Stadtmauer, Marcelo C. Pasquini, Beth Blackwell, Parameswaran Hari, Asad Bashey, Steven M. Devine, Yvonne A. Efebera, S. Ganguly, Cristina Gasparetto, Nancy L. Geller, Mary M. Horowitz, John Koreth, Kristin Knust, Heather Landau, Claudio G. Brunstein, Philip L. McCarthy, Courtney Nelson, Muzaffar H. Qazilbash, Nina Shah, David H. Vesole, Ravi Vij, Dan T. Vogl, Sergio Giralt, George Somlo, Amrita Krishnan - Journal of Clinical Oncology 2019 cited by 259

  17. Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401

    Authors: David J. Chung, Nina Shah, Juan Wu, Brent R. Logan, Lina Bisharat, Natalie S. Callander, Giulia Cheloni, Kenneth C. Anderson, Thinle Chodon, Binod Dhakal, Steve Devine, Poorvi Somaiya Dutt, Yvonne A. Efebera, Nancy L. Geller, Haider Ghiasuddin, Peiman Hematti, Leona Holmberg, Alan Howard, Bryon D. Johnson, Dimitra Karagkouni, Hillard M. Lazarus, Ehsan Malek, Philip L. McCarthy, David H. McKenna, Adam Mendizabal, Ajay K. Nooka, Nikhil C. Munshi, Lynn O’Donnell, Aaron P. Rapoport, Jane Reese, Jacalyn Rosenblatt, Robert J. Soiffer, Dina Stroopinsky, Lynne Uhl, Ioannis S. Vlachos, Edmund K. Waller, James W. Young, Marcelo C. Pasquini, David Avigan - Clinical Cancer Research 2023 cited by 29

  18. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

    Authors: Yoshiyuki Takahashi, Nanae Harashima, Sachiko Kajigaya, Hisayuki Yokoyama, Elena Cherkasova, J. Philip McCoy, Ken‐ichi Hanada, Othon J. Mena, Roger Kurlander, Abdul Tawab, Ramaprasad Srinivasan, Andreas Lundqvist, Elizabeth Malinzak, Nancy L. Geller, Michael I. Lerman, Richard Childs - Journal of Clinical Investigation 2008 cited by 186

  19. Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)

    Authors: Angela Dispenzieri, Amrita Krishnan, Bonnie K. Arendt, Beth Blackwell, Paul K. Wallace, Surendra Dasari, Dan T. Vogl, Yvonne A. Efebera, Mingwei Fei, Nancy L. Geller, Sergio Giralt, Theresa Hahn, Alan Howard, Mindy Kohlhagen, Heather Landau, Parameswaran Hari, Marcelo C. Pasquini, Muzaffar H. Qazilbash, Philip L. McCarthy, Nina Shah, David H. Vesole, Edward A. Stadtmauer, David Murray - Blood Cancer Journal 2022 cited by 40

  20. Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).

    Authors: Parameswaran Hari, Marcelo C. Pasquini, Edward A. Stadtmauer, Raphael Fraser, Mingwei Fei, Steven M. Devine, Yvonne A. Efebera, Nancy L. Geller, Mary M. Horowitz, John Koreth, Heather Landau, Philip L. McCarthy, Muzaffar H. Qazilbash, Nina Shah, David H. Vesole, Dan T. Vogl, George Somlo, Amrita Krishnan, Sergio Giralt - Journal of Clinical Oncology 2020 cited by 102

  21. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 — The perspective of NIH clinical trialists

    Authors: Laurence S. Freedman, Richard Simon, Mary A. Foulkes, Lawrence M. Friedman, Nancy L. Geller, David J. Gordon, Richard L. Mowery - Controlled Clinical Trials 1995 cited by 316

  22. Management Practices and Major Infections After Cardiac Surgery

    Authors: Annetine C. Gelijns, Alan J. Moskowitz, Michael A. Acker, Michael Argenziano, Nancy L. Geller, John D. Puskas, Louis P. Perrault, Peter K. Smith, Irving L. Kron, Robert E. Michler, Marissa A. Miller, Timothy J. Gardner, Deborah D. Ascheim, Gorav Ailawadi, Pamela Lackner, Lyn A. Goldsmith, Sophie Robichaud, Rachel Miller, Eric A. Rose, T. Bruce Ferguson, Keith A. Horvath, Ellen Moquete, Michael K. Parides, Emilia Bagiella, Patrick T. O’Gara, Eugene H. Blackstone - Journal of the American College of Cardiology 2014 cited by 182

  23. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction

    Authors: Michaël Domanski, Derek V. Exner, Craig B. Borkowf, Nancy L. Geller, Yves Rosenberg, Marc A. Pfeffer - Journal of the American College of Cardiology 1999 cited by 301

  24. Both Light Intensity and Moderate‐to‐Vigorous Physical Activity Measured by Accelerometry Are Favorably Associated With Cardiometabolic Risk Factors in Older Women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study

    Authors: Michael J. LaMonte, Cora E. Lewis, David M. Büchner, Kelly R. Evenson, Eileen Rillamas‐Sun, Chongzhi Di, I‐Min Lee, John Bellettiere, Marcia L. Stefanick, Charles B. Eaton, Barbara V. Howard, Chloe E. Bird, Andrea Z. LaCroix, Jacques E. Rossouw, Shari Ludlam, Dale R. Burwen, Joan McGowan, Leslie Ford, Nancy L. Geller, Garnet L. Anderson, Ross L. Prentice, Charles Kooperberg, JoAnn E. Manson, Rebecca D. Jackson, Cynthia A. Thomson, Jean Wactawski‐Wende, Marian C. Limacher, Robert L. Wallace, Lewis H. Kuller, Sally A. Shumaker - Journal of the American Heart Association 2017 cited by 94